Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burge, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burge, M. R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 24:1502-1503, 2001
© 2001 by the American Diabetes Association, Inc.


Letters: Observations
Letter

Lack of Compliance With Home Blood Glucose Monitoring Predicts Hospitalization in Diabetes

Mark R. Burge, MD

Department of Medicine/Endocrinology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico

Home capillary blood glucose (CBG) monitoring is the standard of care for patients with diabetes (1,2). Patients with type 1 diabetes should monitor their CBG concentration at least three or four times daily, and patients with type 2 diabetes should probably monitor their CBG concentration at least twice a day (1). Nevertheless, up to 67% of patients with diabetes fail to routinely monitor their CBG levels (3). Although the relationship between rigorous home blood glucose monitoring and improved glycemic control is well-established, determinants of compliance with home blood glucose monitoring recommendations are not known. Reported here are the results of a marketing survey exploring attitudes and behaviors surrounding compliance with home CBG monitoring.

My group has previously published a study examining the efficacy of a laser skin perforator for the attainment of capillary blood samples for home CBG monitoring (4). In response to the large number of telephone inquiries received, the manufacturer of this device (Lasette Laser Skin Perforator; Cell Robotics, Albuquerque, NM) mailed out a brief questionnaire examining current home blood glucose monitoring practices and attitudes about this activity . . . [Full Text of this Article]

ACKNOWLEDGMENTS

FOOTNOTES

References


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Public HealthHome page
J. M. Robbins and D. A. Webb
Hospital Admission Rates for a Racially Diverse Low-Income Cohort of Patients With Diabetes: The Urban Diabetes Study
Am J Public Health, July 1, 2006; 96(7): 1260 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
J. Unger
Case Study: A 62-Year-Old Man With ""Brittle"" Type 1 Diabetes
Clin. Diabetes, January 1, 2002; 20(1): 37 - 39.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.